Ligand stimulation of CD155 alpha inhibits cell adhesion and enhances cell migration in fibroblasts
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Authors: Oda, T; Ohka, S; Nomoto, A
Abstract
CD155 (poliovirus receptor) localizes in cell-matrix adhesions and cell-cell junctions, but its role in the regulation of cell adhesion and cell motility has not been investigated. We identified a conserved immunoreceptor tyrosine-based inhibitory motif (ITIM) in the cytoplasmic domain of human CD155alpha. The ITIM was tyrosine-phosphorylated upon binding of anti-CD155 monoclonal antibody D171, poliovirus, and DNAM-1 (CD226) to human CD155alpha, and recruited SH2-domain-containing tyrosine phosphatase-2 (SHP-2). After CD155alpha stimulation with its ligands, cell adhesion was inhibited and cell motility was enhanced, effects that were associated with the phosphorylation of ITIM by Src kinases and accompanied by dephosphorylation of focal adhesion kinase and paxillin. These effects were abolished by introducing a point-mutation in Y398F into the ITIM of CD155alpha and by coexpression of a dominant negative SHP-2 mutant with CD155alpha. These results suggest that CD155alpha plays a role in the regulation of cell adhesion and cell motility. (C) 2004 Elsevier Inc. All rights reserved.
CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation
FRONTIERS IN IMMUNOLOGY
Authors: Shapiro, Melanie R.; Yeh, Wen-, I; Longfield, Joshua R.; Gallagher, John; Infante, Caridad M.; Wellford, Sarah; Posgai, Amanda L.; Atkinson, Mark A.; Campbell-Thompson, Martha; Lieberman, Scott M.; Serreze, David V.; Geurts, Aron M.; Chen, Yi-Guang; Brusko, Todd M.
Abstract
The costimulatory molecule CD226 is highly expressed on effector/memory T cells and natural killer cells. Costimulatory signals received by T cells can impact both central and peripheral tolerance mechanisms. Genetic polymorphisms inCD226have been associated with susceptibility to type 1 diabetes and other autoimmune diseases. We hypothesized that genetic deletion ofCd226in the non-obese diabetic (NOD) mouse would impact type 1 diabetes incidence by altering T cell activation. CD226 knockout (KO) NOD mice displayed decreased disease incidence and insulitis in comparison to wild-type (WT) controls. Although female CD226 KO mice had similar levels of sialoadenitis as WT controls, male CD226 KO mice showed protection from dacryoadenitis. Moreover, CD226 KO T cells were less capable of adoptively transferring disease compared to WT NOD T cells. Of note, CD226 KO mice demonstrated increased CD8(+)single positive (SP) thymocytes, leading to increased numbers of CD8(+)T cells in the spleen. Decreased percentages of memory CD8(+)CD44(+)CD62L(-)T cells were observed in the pancreatic lymph nodes of CD226 KO mice. Intriguingly, CD8(+)T cells in CD226 KO mice showed decreased islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)-tetramer and CD5 staining, suggesting reduced T cell receptor affinity for this immunodominant antigen. These data support an important role for CD226 in type 1 diabetes development by modulating thymic T cell selection as well as impacting peripheral memory/effector CD8(+)T cell activation and function.